Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Folotyn


Contraindicated
Teratogenic

Contraindicated
Folotyn :
Type Medicine Authorised
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Mundipharma
Responsible Party Mundipharma Medical Company
Origin Switzerland
Manufacturer Baxter Oncology GmbH
Origin Germany
ATC L01BA05

Your comment will appear shortly after approval

Different Units By MoH Code

Folotyn  MoH 7978 :
Form Solution for injection
Packaging Bottle
Package Size 1x1ml
Strength 20mg/ml
Public Price 5629013 L.L.
Stratum E2
NSSF ✔
Quarantine ✔
Reg. Number 107614/1
Submission date 01/01/2014
Registration Year 2015


Price Comparison

● Country: Abu Dhabi
● Package Size: 1
● Public Price: 18076.5 AED ( 436,746,316.50 LBP )
● Pack size unit used: 1
● Cost/Unit: 18076,5 AED ( 436,734,236.00 LBP )
● Pharmacy Price: 15398.9 AED ( 372052822.9 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 1 Ampoule
● Public Price: 18076.5 AED ( 436,746,316.50 LBP )
● Pack size unit used: 1
● Cost/Unit: 18076,5 AED ( 436,734,236.00 LBP )
● Pharmacy Price: 15398.91 AED ( 372053064.51 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Oman
● Package Size: 1
● Public Price: 1851.31 OMR ( 427,160,161.54 LBP )
● Pack size unit used: 1
● Cost/Unit: 1851,31 OMR ( 427,088,634.00 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: KSA
● Package Size: 1
● Public Price: 15091.7 SAR ( 356,767,788.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 15091,7 SAR ( 356,751,240.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Lebanon
● Form: Solution for injection
● Package Size: 1x1ml
● Public Price: 5629013 LBP ( 5,629,013.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 5629013 LBP ( 5,629,013.00 LBP )
● Pricing Date: 13/06/2024

● Country: Italy
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: France
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Reference: ansm
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: Belgium
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Reference: cbip
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: Spain
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: Sweden
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: UK
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Reference: DMD
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: Czech Republic
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Reference: SUKL
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: The Netherlands
● Package Size: 1
● Reference: Zorginstituut Nederland
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: Malta
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: Germany
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: Poland
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: Finland
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Reference: Kela
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: Roumania
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: Austria
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Reference: Austrian Medicines and Medical Devices Agency
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: Hungary
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: Portugal
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: Bulgary
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

● Country: Greece
● Package Size: 1
● Reference: National Organization for Medicines
● Pricing Date: 21/10/2019
● Type: Medicine Non Marketed

● Country: Denmark
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Reference: Danish Medicine Agency
● Pricing Date: 21/10/2020
● Type: Medicine Rejected

● Country: Ireland
● Package Size: 1
● Medica Comments: EMA refusal date: 21/06/2012 for lack of clear improvement seen in the condition of the patients
● Pricing Date: 21/10/2019
● Type: Medicine Rejected

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Peripheral T-cell lymphoma :
● Cost/Unit: 18076,5 AED ( 436,734,236.00 LBP )
● Cost/Day: 36153 AED ( 873,492,633.00 LBP )
● Cost/Month: 144612 AED ( 3,493,970,532.00 LBP )
Peripheral T-cell lymphoma :
● Cost/Unit: 18076,5 AED ( 436,734,236.00 LBP )
● Cost/Day: 36153 AED ( 873,492,633.00 LBP )
● Cost/Month: 144612 AED ( 3,493,970,532.00 LBP )
Peripheral T-cell lymphoma :
● Cost/Unit: 1851,31 OMR ( 427,088,634.00 LBP )
● Cost/Day: 3702,62 OMR ( 854,177,268.00 LBP )
● Cost/Month: 14810,48 OMR ( 3,417,170,540.00 LBP )
Peripheral T-cell lymphoma :
● Cost/Unit: 15091,7 SAR ( 356,751,240.00 LBP )
● Cost/Day: 30183,4 SAR ( 713,526,120.00 LBP )
● Cost/Month: 120733,6 SAR ( 2,854,128,120.00 LBP )
Peripheral T-cell lymphoma :
● Cost/Unit: 5629013 LBP ( 5,629,013.00 LBP )
● Cost/Day: 11258026 LBP ( 11,258,026.00 LBP )
● Cost/Month: 45032104 LBP ( 45,032,104.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info